Archive for the ‘
Sales & Marketing ’ Category
Wednesday, August 26th, 2009
Recently Medical Crossfire, a platform that has produced more than a thousand panel discussions on various areas of physician expertise, took the full plunge into the digital age by converting itself into an online video journal at MedicalCrossfire.com. I spoke with Medical Crossfire editor Cheryl Dandrea to find out more ...
Posted in
Sales & Marketing |
No Comments »
Wednesday, June 24th, 2009
In a rare show of solidarity, both innovative and generic pharmaceutical companies are stacking the barricades in response to sharp criticism of generic licensing agreements by the chairman of the Federal Trade Commission. Accusing new FTC chairman Jon Leibowitz of both fuzzy assumptions and unwarranted conclusions, the leaders of the ...
Posted in
Sales & Marketing |
No Comments »
Tuesday, June 23rd, 2009
As referenced in an earlier post, the pharmaceutical industry appears to have let its market data go stale in recent months, neglecting to update its market research as a way to cut costs. Of course, it’s never just that simple. Marketers basically do two types of research. One is regular ...
Posted in
Sales & Marketing |
No Comments »
Tuesday, June 16th, 2009
Pharma CRM and data solutions provider Cegedim Dendrite took its show on the road today, holding its U.S. Roadshow at The New York Palace in NYC. The event was designed to highlight the company's continued financial stability and its success in 2008. The company, which is the product of the ...
Posted in
Sales & Marketing |
No Comments »
Wednesday, June 10th, 2009
Recently, FDA issued a draft guidance titled Presenting Risk Information in Prescription Drug and Medical Device Promotion. The draft guidance outlines factors FDA considers when evaluating ads and labeling for prescription drugs, providing examples to illustrate the agency’s thinking. According to FDA, the guidance was issued in response to requests ...
Posted in
FDA Files, Sales & Marketing |
1 Comment »
Thursday, May 28th, 2009
... some poll numbers from the CME provider Pri-Med (pri-med.com) show that the economic squeeze has significantly altered the behavior of both doctors and patients. In a survey of 473 clinicians that the company completed May 21, Pri-Med found that:
-Â 90% of clinicians polled have seen changes In patient behaviors
-Â 95% have ...
Posted in
Sales & Marketing, Uncategorized |
No Comments »
Tuesday, May 19th, 2009
Due to real estate constraints, we can't always include every interesting article that we want in the paper issue of Med Ad News. The article below didn't quite make the cut for May's Sales & Marketing department. But I thought it was interesting, both for the rebuke of FDA and ...
Posted in
Sales & Marketing |
No Comments »
Tuesday, April 7th, 2009
FDA has cracked down on sponsored links that show up on Google and other search engines on behalf of 14 different pharmaceutical companies: Bayer AG, Biogen Idec Inc., Boehringer Ingelheim Pharmaceuticals Inc., Cephalon Inc., Forest Laboratories Inc., Genentech Inc., GlaxoSmithKline, Johnson & Johnson, Eli Lilly and Co., Merck & Co., ...
Posted in
DTC advertising, Legal actions, Patient education, Sales & Marketing |
2 Comments »
Tuesday, March 31st, 2009
Now that my work on the April issue is (nearly) complete, I can turn my attention to our annual DTC special report, scheduled for May. And just in time, The Nielsen Company has released its list of 2008's most-recalled pharmaceutical and vaccine ads. You may remember that list as coming ...
Posted in
DTC advertising, Sales & Marketing |
1 Comment »
Wednesday, March 11th, 2009
The fallout from the Supreme Court's Wyeth v. Levine decision will be added burden not just for pharmaceutical manufacturers, but FDA as well, according to Gary Liberson and Craig Wylie in PA Consulting's Life Sciences & Healthcare practice. Pharmaceutical marketers will be burdened to meet individual State product care laws. ...
Posted in
Sales & Marketing |
No Comments »
|
|
